Airgas USA, LLC

Form 483 issued March 4, 2022 · Grand Junction, Colorado

Inspection
Mar 1 – Mar 4, 2022
Observations
2
Pages
5
FEI number
1750002

In short: On March 4, 2022, FDA issued a Form 483 with 2 observations to Airgas USA, LLC in Grand Junction, Colorado (FEI 1750002) after an inspection that ran Mar 1 – Mar 4, 2022. The investigators were Dustin M. James and Matthew R. Clabeaux. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

2 of 2 observations on this 483 concern laboratory controls.

Laboratory controls2

Most cited: 21 CFR 211.160(b)(4) (1×) · 211.194(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The calibration of instruments and gauges is not done at suitable intervals in accordance with…

  2. 02

    Laboratory records do not include complete records of the periodic…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Airgas USA, LLC?

FDA listed 2 observations on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Airgas USA, LLC?

Dustin M. James and Matthew R. Clabeaux are named on this Form 483, for the inspection of Mar 1 – Mar 4, 2022. Each investigator has a profile showing what they cite most.

When was Airgas USA, LLC inspected by FDA?

The inspection ran Mar 1 – Mar 4, 2022, and the Form 483 is dated March 4, 2022.

How do I get the full Form 483 for Airgas USA, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free